• 제목/요약/키워드: enhancer

검색결과 737건 처리시간 0.023초

염분과 미량원소가 Heterosigma akashiwo (Raphidophyceae) 성장률에 미치는 영향 (Effect of Salinity and Micronutrients on the Growth Rate of Bloom from Heterosigma akashiwo (Raphidophyceae))

  • 이주연;장만;한명수
    • 환경생물
    • /
    • 제32권2호
    • /
    • pp.129-137
    • /
    • 2014
  • Heterosigma akashiwo의 대발생 기작을 규명하기 위하여 환경 요인들에 따른 성장률을 각각 비교하였다. 환경요인, 염분, N:P ratio, 철 (Fe), 셀레늄 (Se)을 대상으로 국내 배양주 2종과 국외 배양주 1종의 성장 특성을 확인하였다. 그 결과, H. akashiwo 배양주는 염분과 철의 농도에 따른 최대 성장률의 특성을 기반으로 지리학적 특이성을 찾기는 힘들었으나, 염분에 대한 내성은 강하여 10 psu에서 40 psu에서 생존이 가능한 것으로 나타났다. N:P ratio와 셀레늄은 국내 배양주와 국외 배양주의 차이를 보였다. 이와 같은 생리학적 특성에 대한 결과를 보았을 때, H. akashiwo가 염분에 대한 높은 내성을 기반으로 우점할 수 있으며, 풍부한 영양염을 이용하여 더욱 빠른 성장으로 대발생을 가능하게 할 수 있을 것이라고 판단된다.

불포화 폴리(3-히드록시알칸오에이트)를 기질로 한 경피제제의 약물방출 (Transdermal Drug Release of Polymer Matrix of Unsaturated Poly(3-hydroxyalkanoate))

  • 이수홍;신병철;이영하;김형우;김영백;김승수
    • 폴리머
    • /
    • 제27권6호
    • /
    • pp.536-541
    • /
    • 2003
  • 불포화 폴리(3-히드록시알칸오에이트) (UPHA)를 생합성하고 이 고분자 매트릭스 내에서의 약물방출 경향을 조사하였다. UPHA의 생합성에 사용된 균주는 Pseudomonas oleovorans (ATCC 29347)이고 탄소원은 10-undecenoic acid를 사용하였으며 산-염기조절방법 배취형태 발효법을 이용하여 미생물 배양을 행하였다. 생합성된 UPHA는 $^1$H- 및 $^{13}$C-NMR, FT-IR, GPC 및 DSC 등을 사용하여 물리 및 화학적 분석을 행하였다. 약물방출 실험은 확산셀을 이용하여 모델약물인 케토프로펜의 방출량을 HPLC를 이용하여 측정하였고 UPHA의 가교도, 패취두께, 경피투과 향상제 등의 영향에 대하여 조사하였다. UPHA의 가교도의 증가에 따라 약물방출 속도가 늦어지고 약물방출 속도가 일정해지는 경향을 나타내었다. 경피투과용 패취의 두께가 두꺼워질수록 약물방출 지속시간이 길어지고 경피투과 향상제인 프로필렌 글리콜의 함량 증가에 따라 방출 속도가 향상되는 경향을 나타내었다.

근위축성측삭경화증의 SOD1-G93A 유전자 이식 마우스 모델에서 라파마이신의 신경보호효과 (Neuroprotective Effect of Rapamycin (Autophagy Enhancer) in Transgenic SOD1-G93A Mice of Amyotrophic Lateral Sclerosis)

  • 안석원;전계선;박광열;홍윤호;이광우;성정준
    • Annals of Clinical Neurophysiology
    • /
    • 제15권2호
    • /
    • pp.53-58
    • /
    • 2013
  • Background: The autophagy is the major route for lysosomal degradation of misfolded protein aggregates and oxidative cell components. We hypothesized that rapamycin (autophagy enhancer) would prolong the survival of motor neuron and suppress the disease progression in amyotrophic lateral sclerosis (ALS). Methods: A total of 24 transgenic mice harboring the human G93A mutated SOD1 gene were used. The clinical status involving rotarod test and survival, and biochemical study of ALS mice model were evaluated. Results: The onset of symptoms was significantly delayed in the rapamycin administration group compared with the control group. However, after the clinical symptom developed, the rapamycin exacerbated the disease progression and shortened the survival of ALS mice model, and apoptosis signals were up-regulated compared with control group. Conclusions: Even though further detailed studies on the relevancy between autophagy and ALS will be needed, our results revealed that the rapamycin administration was not effective for being novel promising therapeutic strategy in ALS transgenic mice and exacerbated the apoptosis.

P-요소를 이용한 노랑초파리 난소에서의 세포특이적 유전자발현의 검출 (Probing Cell-Type Specific Gene Expression in the Ovarian Cells of Drosophila by P-Element Mediated Enhancer Detection)

  • 계명찬;조경상;김경진;이정주
    • 한국동물학회지
    • /
    • 제38권4호
    • /
    • pp.505-513
    • /
    • 1995
  • P-lement의 germ line transformation을 이용하여 초파리 난소에서의 세포특이적 유전자발현 양상을 조사하였다. 표지유전자인 lacZ의 발현양상은 생식세포, 체세포, 두 종류의 세포에서 모두 발현되는 경우로 대별되며, 생식세포에서 lacZ의 발현은 조세포 또는 조세포와 난자에서 동시적으로 발현되는 경우로 구분되었다. 난자주변 난포세포에서의 lacZ 발현은 난자형성 9-10기 난포의 경우 모든 세포에서 균일하게 발현되거나 일부 세포에서만 발현되는 양상으로 구분되었다. 일부의 난포세포에서 발현되는 경우 난자와 조세포 경계의 난포세포에서 발현되는 경우, 이들을 제외한 난포세포에서 발현되는 경우로 구분되었다. 난자주위의 난포세포에서 난자의 전후축을 따른 구배현상도 관찰되었다. 극세포 또는 경계세포에서 발현되는 3개의 독립라인을 분리하였다. 독립된 EDL의 난소에서 나타난 lacZ의 발현양상은 초파리 난자형성에 관여하는 유전자의 시간과 공간적인 발현을 반영하며 이들 유전자 분리의 기초를 제공할 것으로 사료된다.

  • PDF

Sodium butyrate와 sodium pyruvate 첨가에 의한 hCTLA4Ig 생산성 증대 (Enhanced Production of hCTLA4Ig by Adding Sodium Butyrate and Sodium Pyruvate)

  • 유미희;김수진;권준영;남형진;김동일
    • KSBB Journal
    • /
    • 제26권5호
    • /
    • pp.386-392
    • /
    • 2011
  • Human cytotoxic T-lymphocyte antigen 4-immunoglobulin (hCTLA4Ig), an immunosuppressive agent, was expressed in transgenic rice cells using RAmy3D promoter and RAmy1A signal peptide for the inducible production and secretion into culture media by sugar depletion. In this study, sodium butyrate was used as a small molecular enhancer (SME) to enhance the production of hCTLA4Ig in transgenic rice cell suspension cultures. When 1 mM sodium butyrate was added in sugar-free media, relative viability was not reduced, while the productivity was improved 1.3-fold. In addition, by supplementing 87 mM sodium pyruvate as an alternative energy source during the production phase, death rate of the cells was decreased. When sodium pyruvate was not added, most cells became dead at day 6. However, by adding sodium pyruvate, 18% of viability can be maintained until day 10 and the production of hCTLA4Ig was enhanced 1.4-fold. When the combination of sodium pyruvate and sodium butyrate at optimum concentrations was added, the highest viability and hCTLA4Ig production could be obtained. The highest level of hCTLA4Ig reached up to 35 mg/L at day 10.

Prognostic and Clinicopathological Significance of Transducer-Like Enhancer of Split 1 Expression in Gastric Cancer

  • Lee, Ji-Hye;Son, Myoung-Won;Kim, Kyung-Ju;Oh, Mee-Hye;Cho, Hyundeuk;Lee, Hyun Ju;Jang, Si-Hyong;Lee, Moon Soo
    • Journal of Gastric Cancer
    • /
    • 제16권1호
    • /
    • pp.21-27
    • /
    • 2016
  • Purpose: Transducer-like enhancer of split 1 (TLE1) is a member of the Groucho/TLE family of transcriptional co-repressors that regulate the transcriptional activity of numerous genes. TLE1 is involved in the tumorigenesis of various tumors. We investigated the prognostic significance of TLE1 expression and its association with clinicopathological parameters in gastric cancer (GC) patients. Materials and Methods: Immunohistochemical analysis of six tissue microarrays was performed to examine TLE1 expression using 291 surgically resected GC specimens from the Soonchunhyang University Cheonan Hospital between July 2006 and December 2009. Results: In the non-neoplastic gastric mucosa, TLE1 expression was negative. In GC, 121 patients (41.6%) were positive for TLE1. The expression of TLE1 was significantly associated with male gender (P=0.021), less frequent lymphatic (P=0.017) or perineural invasion (P=0.029), intestinal type according to the Lauren classification (P=0.024), good histologic grade (P<0.001), early pathologic T-stage (P=0.012), and early American Joint Committee on Cancer stage (P=0.022). In the Kaplan-Meier analysis, the TLE1 expression was significantly associated with longer disease-free (P=0.022) and overall (P=0.001) survival rates. Conclusions: We suggested that TLE1 expression is a good prognostic indicator in GCs.

Effect of yoghurt with a Bifidobacteria enhancer and dietary fiber on irritable bowel syndrome

  • Cho, Young Hoon;Bae, Hyoung Churl;Nam, Myoung Soo
    • 농업과학연구
    • /
    • 제48권3호
    • /
    • pp.575-587
    • /
    • 2021
  • This study was carried out to investigate the effects of supplementation with a Bifidobacteria enhanced yogurt (BE0623 yogurt), which includes Bifidobacterium lactis BB12, Lactobacillus acidophilus, Streptococcus thermophilus, and Bifidobacterium lactis, in the management of irritable bowel syndrome (IBS) using animal models and clinical trials. In a rat study, a loperamide-treated group (LOP) showed reduced water content in fecal pellets but showed an increased number of fecal pellets in the distal colon. In addition, the BE0623 yogurt (L-BE0623Y) group had the fewest fecal pellets in the distal colon. Regarding the serum lipid parameters, the LOP group had a high-density lipoprotein (HDL)/total cholesterol ratio that was 43% lower than that of a normal water group (NOR), but the outcome for the L-BE0623Y group was 27% lower than the NOR group. In a human study, 116 adults with IBS were sampled as subjects and fed 300 mL of yogurt per day for an eight week period. There was an IBS improvement in the L-BE0623Y and commercial yogurt (L-CY) groups, though flatulence, stool consistency and frequency of defecation outcomes were also noted. Specifically, the L-BE0623Y treatment group showed significant effects with regard to defecation duration and urgency after the consumption of the yogurt used in this study. These results suggest that the Bifidobacteria-enhanced yogurt has superior effects with regard to relieving loperamide-induced constipation in rats and that regular consumption of L-BE0623Y is effective to improve IBS in humans.

CCAAT/enhancer-binding protein beta (C/EBPβ) is an important mediator of 1,25 dihydroxyvitamin D3 (1,25D3)-induced receptor activator of nuclear factor kappa-B ligand (RANKL) expression in osteoblasts

  • Jo, Sungsin;Lee, Yun Young;Han, Jinil;Lee, Young Lim;Yoon, Subin;Lee, Jaehyun;Oh, Younseo;Han, Joong-Soo;Sung, Il-Hoon;Park, Ye-Soo;Kim, Tae-Hwan
    • BMB Reports
    • /
    • 제52권6호
    • /
    • pp.391-396
    • /
    • 2019
  • Receptor activator of nuclear factor kappa B ligand (RANKL) expression in osteoblasts is regulated by 1,25-dihydroxyvitamin D3 (1,25D3). CCAAT/enhancer-binding protein beta ($C/EBP{\beta}$) has been proposed to function as a transcription factor and upregulate RANKL expression, but it is still uncertain how $C/EBP{\beta}$ is involved in 1,25D3-induced RANKL expression of osteoblasts. 1,25D3 stimulation increased the expression of RANKL and $C/EBP{\beta}$ genes in osteoblasts and enhanced phosphorylation and stability of these proteins. Moreover, induction of RANKL expression by 1,25D3 in osteoblasts was downregulated upon knockdown of $C/EBP{\beta}$. In contrast, $C/EBP{\beta}$ overexpression directly upregulated RANKL promoter activity and exhibited a synergistic effect on 1,25D3-induced RANKL expression. In particular, 1,25D3 treatment of osteoblasts increased $C/EBP{\beta}$ protein binding to the RANKL promoter. In conclusion, $C/EBP{\beta}$ is required for induction of RANKL by 1,25D3.

Doxorubicin에 의해 활성화된 미세 아교세포의 면역반응으로 인한 신경손상에 Noni가 미치는 영향 (Noni Inhibits Neuronal Damage Caused by the Immune Reaction of Microglial Cells Activated by Doxorubicin)

  • 정세화;이성민;하지선;양승주;김평환
    • 대한임상검사과학회지
    • /
    • 제52권4호
    • /
    • pp.389-397
    • /
    • 2020
  • Microglial cells function as major immune cells in the brain, playing an important role in the protection and damage of neurons. BV2 microglia, activated by drug stimulation, secrete inflammatory cytokines by activating the nuclear factor kappa-light-chain-enhancer of the activated B cells pathway and are involved in neuroinflammatory and immune responses. The overactivation of microglia by stimuli can cause neuronal damage, leading to brain disease. Noni, a natural product, reduces the activity of microglia to prevent neuronal damage and is a potential natural medicine because it exerts excellent regeneration and anti-inflammatory effects on damaged cells. In this study, when noni was used to treat BV2 cells stimulated by the anti-cancer drug doxorubicin, it reduced the release of pro-inflammatory cytokines from BV2. On the other hand, neuronal damage is a side effect of doxorubicin. Therefore, the cytokines released from doxorubicin-stimulated BV2 cells treated with noni had a positive effect on the neuronal viability compared to those released from doxorubicin-stimulated BV2 cells not treated with Noni. Thus, Noni increases neuronal viability. These results suggest that noni inhibits the release of cytokines by regulating the nuclear factor kappa-light-chain-enhancer of the activated B cells pathway of BV2, thereby inhibiting neuronal damage.

Gossypol Induces Apoptosis of Human Pancreatic Cancer Cells via CHOP/Endoplasmic Reticulum Stress Signaling Pathway

  • Lee, Soon;Hong, Eunmi;Jo, Eunbi;Kim, Z-Hun;Yim, Kyung June;Woo, Sung Hwan;Choi, Yong-Soo;Jang, Hyun-Jin
    • Journal of Microbiology and Biotechnology
    • /
    • 제32권5호
    • /
    • pp.645-656
    • /
    • 2022
  • Gossypol, a natural phenolic aldehyde present in cotton plants, was originally used as a means of contraception, but is currently being studied for its anti-proliferative and anti-metastatic effects on various cancers. However, the intracellular mechanism of action regarding the effects of gossypol on pancreatic cancer cells remains unclear. Here, we investigated the anti-cancer effects of gossypol on human pancreatic cancer cells (BxPC-3 and MIA PaCa-2). Cell counting kit-8 assays, annexin V/propidium iodide staining assays, and transmission electron microscopy showed that gossypol induced apoptotic cell death and apoptotic body formation in both cell lines. RNA sequencing analysis also showed that gossypol increased the mRNA levels of CCAAT/enhancer-binding protein homologous protein (CHOP) and activating transcription factor 3 (ATF3) in pancreatic cancer cell lines. In addition, gossypol facilitated the cleavage of caspase-3 via protein kinase RNA-like ER kinase (PERK), CHOP, and Bax/Bcl-2 upregulation in both cells, whereas the upregulation of ATF was limited to BxPC-3 cells. Finally, a three-dimensional culture experiment confirmed the successful suppression of cancer cell spheroids via gossypol treatment. Taken together, our data suggest that gossypol may trigger apoptosis in pancreatic cancer cells via the PERK-CHOP signaling pathway. These findings propose a promising therapeutic approach to pancreatic cancer treatment using gossypol.